Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244226 · ClinicalTrials.gov registry record · Phase 2
Pediatric Pain Optimization After Tonsillectomy
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT05244226 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 66 participants.
The verdict
NCT05244226, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery.
Interventions
- DRUG Methadone
- DRUG Fentanyl/Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2022-04-08 |
| Est. Completion | 2023-05-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05244226
The ClinicalTrials.gov registry entry for NCT05244226 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT05244226 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05244226 about?
NCT05244226 is a clinical study titled "Pediatric Pain Optimization After Tonsillectomy". The purpose of this study is to compare the use of short acting opioids (fentanyl/hydromorphone) with long acting opioids (methadone) for pain control following tonsillectomy surgery.
What is the current status of trial NCT05244226?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2022-04-08. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT05244226?
The interventions under investigation include: Methadone (DRUG), Fentanyl/Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT05244226?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.